Takeda has bought a licence for a coeliac disease drug from COUR Pharmaceuticals, after the US biotech announced supportive phase 2a trial data. Gastrointestinal diseases are one of the Japanese ...

Learn HTML, CSS, and JavaScript in simple terms with this beginner-friendly guide for 2026. Understand how these three core web technologies work together to build modern websites and create a strong ...

CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

It will release on the service early in the morning. The series is based on the popular manga by Inagaki Riichiro, which appeared in Shonen Jump Magazine. Here is everything you need to know about “Dr ...

Cour Pharmaceuticals, the Chicago-based clinical-stage biotechnology company, says its first patient has been dosed in the phase 1b/2a clinical trial of a treatment that it hopes will address ...

Can you explain object-oriented programming to me like I'm 5 years old? Probably not. But here's a straightforward explanation of what OOP is ... Follow the essential steps to download Java 21, ...

Cour Pharmaceuticals, a local biotech startup that’s raised north of $100 million from investors, has inked a new licensing deal with a Roche subsidiary that’s valued at more than $900 million. The ...